Avient (AVNT) Form 4 AVIENT / Robert M Patterson ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Patterson Robert M

(Last) (First) (Middle)

AVIENT CENTER

33587 WALKER ROAD

(Street)

AVON LAKE OH 44012

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2021		I		121,277.52	D	$52.49	0(1)	I	Supplemental Plan
Common Stock	05/07/2021		G	V	5,000	D	$0	385,242(2)	D
Common Stock	08/27/2021		M		66,700	A	$38.27	451,942	D
Common Stock	08/27/2021		D		56,645	D	$52.49	395,297	D
Common Stock	08/27/2021		M		105,200	A	$24.98	500,497	D
Common Stock	08/27/2021		D		74,518	D	$52.49	425,979	D
Common Stock	08/27/2021		M		118,200	A	$34.1	544,179	D
Common Stock	08/27/2021		D		95,156	D	$52.49	449,023	D
Common Stock	08/27/2021		M		63,034	A	$41.89	512,057	D
Common Stock	08/27/2021		D		55,951	D	$52.49	456,106	D
Common Stock	08/27/2021		M		102,300	A	$31.54	558,406	D
Common Stock	08/27/2021		D		79,579	D	$52.49	478,827	D
Common Stock	08/27/2021		M		57,517	A	$31.48	536,344	D
Common Stock	08/27/2021		D		44,706	D	$52.49	491,638(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$38.27	08/27/2021		M			66,700	(4)	02/04/2025	Common Stock	66,700	$0	0	D
Stock Appreciation Rights	$24.98	08/27/2021		M			105,200	(5)	02/10/2026	Common Stock	105,200	$0	0	D
Stock Appreciation Rights	$34.1	08/27/2021		M			118,200	(6)	02/15/2027	Common Stock	118,200	$0	0	D
Stock Appreciation Rights	$41.89	08/27/2021		M			63,034	(7)	02/14/2028	Common Stock	63,034	$0	31,516	D
Stock Appreciation Rights	$31.54	08/27/2021		M			102,300	(8)	02/11/2029	Common Stock	102,300	$0	51,150	D
Stock Appreciation Rights	$31.48	08/27/2021		M			57,517	(9)	02/10/2030	Common Stock	57,517	$0	115,033	D

Explanation of Responses:

1. Reflects an exempt intra-plan transfer (rule 16b-3(f)) by the reporting person of value out of the Avient stock fund and into one or more other investments under the Issuer's Supplemental Retiremet Benefit Plan pursuant to a pre-arranged trading plan.

2. Includes shares acquired pursuant to dividend reinvestment.

3. The listed SAR transactions were completed pursuant to a pre-arranged trading plan.

4. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.

5. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.

6. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.

7. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.

8. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

9. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.

	/s/ Lisa K. Kunkle, Power of Attorney For: Robert M. Patterson	08/30/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.